tadalafil has been researched along with rutecarpine in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (rutecarpine) | Trials (rutecarpine) | Recent Studies (post-2010) (rutecarpine) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 235 | 1 | 125 |
| Protein | Taxonomy | tadalafil (IC50) | rutecarpine (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.23 | |
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.26 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.022 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 8.7 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.29 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, YH; Huang, XF; Ke, HM; Song, GQ; Wang, JH; Xu, DF | 1 |
1 other study(ies) available for tadalafil and rutecarpine
| Article | Year |
|---|---|
Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cholinergic Antagonists; Cognitive Dysfunction; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Indole Alkaloids; Mice; Models, Molecular; Molecular Structure; Morris Water Maze Test; Phosphodiesterase 5 Inhibitors; Protein Conformation; Quinazolines; Scopolamine | 2020 |